financetom
Business
financetom
/
Business
/
Australia's Syrah, Tesla extend deadline to resolve alleged default in graphite supply deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australia's Syrah, Tesla extend deadline to resolve alleged default in graphite supply deal
Mar 15, 2026 4:41 PM

March 16 (Reuters) - Australian graphite miner Syrah Resources ( SYAAF ) said on Monday it agreed with Tesla to extend for a fourth timea deadline to resolve an alleged default under their graphite supply agreement to June 1.

Tesla had previously issued a notice alleging that Syrah failed to meet an obligation to provide conforming natural graphite active anode material (AAM) samples from its Vidalia facility in Louisiana, according to the company.

The notice required Syrah to cure the alleged default by March 16, failing which Tesla could terminate the offtake agreement covering supply from Syrah's 11.25 kilotons-per-annum AAM facility in Vidalia.

The companies have agreed to amend the deal to extend that deadline to June 1, subject to approval from the U.S. Department of Energy.

The 2021 contract with Tesla, worth 8,000 tons annually for four years, underpins Syrah's Vidalia facility and its broader strategy to become a major U.S. supplier of non-Chinese graphite.

Texas-headquartered Tesla issued the first default notice in July 2025, saying Syrah had failed to deliver conforming active anode material samples from its Vidalia processing facility for use in electric-vehicle batteries.

Syrah said on Monday it does not accept that it is in default but that both parties had agreed to extend the cure date to June 1 while they work together to address the issue.

Shares of Syrah were up 2.9% at A$0.175 as of 2302 GMT.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Axsome's depression treatment fails to meet main goal of late-stage study
Axsome's depression treatment fails to meet main goal of late-stage study
Apr 1, 2025
April 1 (Reuters) - Axsome Therapeutics ( AXSM ) said on Tuesday its experimental drug to treat major depressive disorder failed to meet the main goal of a late-stage study. ...
Eurozone Inflation Is Closing in on The ECB Target, Says Berenberg
Eurozone Inflation Is Closing in on The ECB Target, Says Berenberg
Apr 1, 2025
07:10 AM EDT, 04/01/2025 (MT Newswires) -- Eurozone inflation is receding as expected and will likely dip below the European Central Bank's target of 2% year over year in the months ahead, said Berenberg. In March, consumer prices rose by 2.2% year over year, in line with Reuters consensus expectations and the bank's call, down from the 2.3% inflation rate...
Bayer eyes launch of menopause relief, heart drugs this year
Bayer eyes launch of menopause relief, heart drugs this year
Apr 1, 2025
(Reuters) -Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business amid a high debt burden. In a statement, the German maker of drugs and agricultural supplies said it would bring Beyonttra, also known as...
B2Gold Gets TSX Approval for Normal Course Issuer Bid
B2Gold Gets TSX Approval for Normal Course Issuer Bid
Apr 1, 2025
07:05 AM EDT, 04/01/2025 (MT Newswires) -- B2Gold ( BTG ) on Tuesday said the TSX the company's normal course issuer bid to purchase for cancelation up to around 66 million shares, about 5% of the outstanding stock. The NCIB will commence on April 3, 2025, and expire no later than April 2, 2026. All purchases made under the NCIB...
Copyright 2023-2026 - www.financetom.com All Rights Reserved